• Yingmei Wang, Shiqian Zhang, Lihui Wei, Zhongqiu Lin, Xinyu Wang, Jianliu Wang, Keqin Hua, Manhua Cui, Jiandong Wang, Shixuan Wang, Wen Di, Yudong Wang, Ruifang An, Mingrong Xi, Ruixia Guo, Qi Zhou, Xing Xie, and Fengxia Xue.
• Department of Obstetrics and Gynecology, Tianjin Medical University General Hospital, Tianjin, China.
• J Gynecol Oncol. 2020 Jul 1; 31 (4): e68.

AbstractThe outbreak of coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 has rapidly spread globally. Cancer patients are at a higher risk of being infected with the coronavirus and are more likely to develop severe complications, as compared to the general population. The increasing spread of COVID-19 presents challenges for the clinical care of patients with gynecological malignancies. Concerted efforts should be put into managing gynecological malignancies in an orderly manner by strictly implementing the measures that are specifically developed for controlling the spread of COVID-19. We have drafted Recommendations on Management of Gynecological Malignancies during the COVID-19 Pandemic based on our experience on controlling COVID-19 pandemic in China. We recommend that patients with gynecological malignancies should be managed in hierarchical and individualized manners in combination with local conditions related to COVID-19. Medical care decision should be balanced between controlling COVID-19 pandemic spread and timely diagnosis and treatment for gynecologic oncology patients.Copyright © 2020. Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology.

27 keywords...

hide…